methylprednisolone has been researched along with Thromboembolism, Venous in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bojarian, M; Go, RC; Hosseini, DK; Kim, K; Nyirenda, T; Rahim, M; Rose, KM | 1 |
| Cannegieter, SC; Dekkers, OM; Ehrenstein, V; Horváth-Puhó, E; Johannesdottir, SA; Jørgensen, JO; Pedersen, L; Sørensen, HT; Vandenbroucke, JP | 1 |
2 other study(ies) available for methylprednisolone and Thromboembolism, Venous
| Article | Year |
|---|---|
Methylprednisolone, venous thromboembolism, and association with heparin to 30 days in hospital survival in severe Covid-19 pneumonia.
Topics: Anticoagulants; COVID-19; Follow-Up Studies; Glucocorticoids; Heparin; Hospital Mortality; Humans; Incidence; Methylprednisolone; Retrospective Studies; SARS-CoV-2; Survival Rate; Time Factors; United States; Venous Thromboembolism | 2022 |
Use of glucocorticoids and risk of venous thromboembolism: a nationwide population-based case-control study.
Topics: Aged; Betamethasone; Case-Control Studies; Denmark; Drug Prescriptions; Female; Glucocorticoids; Humans; Hydrocortisone; Incidence; Logistic Models; Male; Methylprednisolone; Middle Aged; Odds Ratio; Prednisolone; Prednisone; Registries; Risk Assessment; Risk Factors; Triamcinolone; Venous Thromboembolism | 2013 |